Quantitative Proteomics Explore the Potential Targets and Action Mechanisms of Hydroxychloroquine

Overview

Journal Molecules

Publisher MDPI

Specialty Biology

Date 2022 Aug 26

PMID 36014414

Authors

Jingxiang Zhao

Zhiqiang Zhao

Wanting Hou

Yue Jiang

Guobin Liu

Xuelian Ren

Kun Liu

Hong Liu

Kaixian Chen

He Huang

Affiliations

Soon will be listed here.

Abstract

Hydroxychloroquine (HCQ) is an autophagy inhibitor that has been used for the treatment of many diseases, such as malaria, rheumatoid arthritis, systemic lupus erythematosus, and cancer. Despite the therapeutic advances in these diseases, the underlying mechanisms have not been well determined and hinder the rational use of this drug in the future. Here, we explored the possible mechanisms and identified the potential binding targets of HCQ by performing quantitative proteomics and thermal proteome profiling on MIA PaCa-2 cells. This study revealed that HCQ may exert its functions by targeting some autophagy-related proteins such as ribosyldihydronicotinamide dehydrogenase (NQO2) and transport protein Sec23A (SEC23A), or regulating the expression of galectin-8 (LGALS8), mitogen-activated protein kinase 8 (MAPK8), and so on. Furthermore, HCQ may prevent the progression of pancreatic cancer by regulating the expression of nesprin-2 (SYNE2), protein-S-isoprenylcysteine O-methyltransferase (ICMT), and cotranscriptional regulator FAM172A (FAM172A). Together, these findings not only identified potential binding targets for HCQ but also revealed the non-canonical mechanisms of HCQ that may contribute to pancreatic cancer treatment.

Citing Articles

Polymorphisms and Pharmacogenomics of : The Past and the Future.

Janda E, Boutin J, De Lorenzo C, Arbitrio M Genes (Basel). 2024; 15(1).

PMID: 38254976 PMC: 10815803. DOI: 10.3390/genes15010087.

References

Gan W, Zhang C, Siu K, Satoh A, Tanner J, Yu S . ULK1 phosphorylates Sec23A and mediates autophagy-induced inhibition of ER-to-Golgi traffic. BMC Cell Biol. 2017; 18(1):22. PMC: 5424413. DOI: 10.1186/s12860-017-0138-8. View

Al-Bari M . Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases. J Antimicrob Chemother. 2015; 70(6):1608-21. PMC: 7537707. DOI: 10.1093/jac/dkv018. View

Kirkin V, Lamark T, Sou Y, Bjorkoy G, Nunn J, Bruun J . A role for NBR1 in autophagosomal degradation of ubiquitinated substrates. Mol Cell. 2009; 33(4):505-16. DOI: 10.1016/j.molcel.2009.01.020. View

Lagier J, Fenollar F, Lepidi H, Giorgi R, Million M, Raoult D . Treatment of classic Whipple's disease: from in vitro results to clinical outcome. J Antimicrob Chemother. 2013; 69(1):219-27. DOI: 10.1093/jac/dkt310. View

Schrezenmeier E, Dorner T . Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology. Nat Rev Rheumatol. 2020; 16(3):155-166. DOI: 10.1038/s41584-020-0372-x. View

Lin Y, Lin J, Wen S, Yang S, Tsai T, Chen H . Chloroquine and hydroxychloroquine inhibit bladder cancer cell growth by targeting basal autophagy and enhancing apoptosis. Kaohsiung J Med Sci. 2017; 33(5):215-223. DOI: 10.1016/j.kjms.2017.01.004. View

Chen Y, Liu P, Shen D, Liu H, Xu L, Wang J . FAM172A inhibits EMT in pancreatic cancer via ERK-MAPK signaling. Biol Open. 2020; 9(2). PMC: 7044457. DOI: 10.1242/bio.048462. View

Savitski M, Reinhard F, Franken H, Werner T, Falth Savitski M, Eberhard D . Tracking cancer drugs in living cells by thermal profiling of the proteome. Science. 2014; 346(6205):1255784. DOI: 10.1126/science.1255784. View

Yang S, Wang X, Contino G, Liesa M, Sahin E, Ying H . Pancreatic cancers require autophagy for tumor growth. Genes Dev. 2011; 25(7):717-29. PMC: 3070934. DOI: 10.1101/gad.2016111. View

10.

Koranda F . Antimalarials. J Am Acad Dermatol. 1981; 4(6):650-5. DOI: 10.1016/s0190-9622(81)70065-3. View

11.

Holdgaard S, Cianfanelli V, Pupo E, Lambrughi M, Lubas M, Nielsen J . Selective autophagy maintains centrosome integrity and accurate mitosis by turnover of centriolar satellites. Nat Commun. 2019; 10(1):4176. PMC: 6744468. DOI: 10.1038/s41467-019-12094-9. View

12.

Brocks D, Mehvar R . Stereoselectivity in the pharmacodynamics and pharmacokinetics of the chiral antimalarial drugs. Clin Pharmacokinet. 2003; 42(15):1359-82. DOI: 10.2165/00003088-200342150-00004. View

13.

Goldberg S, Supko J, Neal J, Muzikansky A, Digumarthy S, Fidias P . A phase I study of erlotinib and hydroxychloroquine in advanced non-small-cell lung cancer. J Thorac Oncol. 2012; 7(10):1602-8. PMC: 3791327. DOI: 10.1097/JTO.0b013e318262de4a. View

14.

Wang L, Lin Y, Huang N, Yu C, Tsai W, Chen J . Hydroxychloroquine-inhibited dengue virus is associated with host defense machinery. J Interferon Cytokine Res. 2014; 35(3):143-56. PMC: 4350140. DOI: 10.1089/jir.2014.0038. View

15.

Wei Y, Pattingre S, Sinha S, Bassik M, Levine B . JNK1-mediated phosphorylation of Bcl-2 regulates starvation-induced autophagy. Mol Cell. 2008; 30(6):678-88. PMC: 2478643. DOI: 10.1016/j.molcel.2008.06.001. View

16.

Onorati A, Dyczynski M, Ojha R, Amaravadi R . Targeting autophagy in cancer. Cancer. 2018; 124(16):3307-3318. PMC: 6108917. DOI: 10.1002/cncr.31335. View

17.

Kersh G . Antimicrobial therapies for Q fever. Expert Rev Anti Infect Ther. 2013; 11(11):1207-14. PMC: 4608426. DOI: 10.1586/14787210.2013.840534. View

18.

Evans A, Lennemann N, Coyne C . BPIFB3 interacts with ARFGAP1 and TMED9 to regulate non-canonical autophagy and RNA virus infection. J Cell Sci. 2020; 134(5). PMC: 7929927. DOI: 10.1242/jcs.251835. View

19.

Cui L, Nakano K, Obchoei S, Setoguchi K, Matsumoto M, Yamamoto T . Small Nucleolar Noncoding RNA SNORA23, Up-Regulated in Human Pancreatic Ductal Adenocarcinoma, Regulates Expression of Spectrin Repeat-Containing Nuclear Envelope 2 to Promote Growth and Metastasis of Xenograft Tumors in Mice. Gastroenterology. 2017; 153(1):292-306.e2. DOI: 10.1053/j.gastro.2017.03.050. View

20.

Zhang J, Zhou Y, Li N, Liu W, Liang J, Sun Y . Curcumol Overcomes TRAIL Resistance of Non-Small Cell Lung Cancer by Targeting NRH:Quinone Oxidoreductase 2 (NQO2). Adv Sci (Weinh). 2020; 7(22):2002306. PMC: 7675185. DOI: 10.1002/advs.202002306. View